MX358750B - Materiales y metodos para el control de enfermedades respiratorias en caninos. - Google Patents

Materiales y metodos para el control de enfermedades respiratorias en caninos.

Info

Publication number
MX358750B
MX358750B MX2016006164A MX2016006164A MX358750B MX 358750 B MX358750 B MX 358750B MX 2016006164 A MX2016006164 A MX 2016006164A MX 2016006164 A MX2016006164 A MX 2016006164A MX 358750 B MX358750 B MX 358750B
Authority
MX
Mexico
Prior art keywords
methods
respiratory disease
canines
materials
disease control
Prior art date
Application number
MX2016006164A
Other languages
English (en)
Spanish (es)
Inventor
Patti C Crawford
Paul J Gibbs
Edward J Dubovi
Ruben O Donis
Jacqueline Katz
William L Castleman
Nancy J Cox
Alexander I Klimov
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of MX358750B publication Critical patent/MX358750B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2016006164A 2005-04-21 2006-04-21 Materiales y metodos para el control de enfermedades respiratorias en caninos. MX358750B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67344305P 2005-04-21 2005-04-21
PCT/US2006/015090 WO2006116082A1 (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Publications (1)

Publication Number Publication Date
MX358750B true MX358750B (es) 2018-08-31

Family

ID=37215064

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2013000210A MX339202B (es) 2005-04-21 2006-04-21 Materiales y metodos para el control de enfermedades respiratorias en caninos.
MX2016006164A MX358750B (es) 2005-04-21 2006-04-21 Materiales y metodos para el control de enfermedades respiratorias en caninos.
MX2018010571A MX2018010571A (es) 2005-04-21 2007-10-22 Materiales y metodos para el control de enfermedades respiratorias en caninos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2013000210A MX339202B (es) 2005-04-21 2006-04-21 Materiales y metodos para el control de enfermedades respiratorias en caninos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018010571A MX2018010571A (es) 2005-04-21 2007-10-22 Materiales y metodos para el control de enfermedades respiratorias en caninos.

Country Status (16)

Country Link
EP (3) EP2495326B1 (OSRAM)
JP (6) JP2008536526A (OSRAM)
KR (3) KR101738937B1 (OSRAM)
CN (3) CN107099512A (OSRAM)
AU (1) AU2006240038B2 (OSRAM)
BR (2) BRPI0610503B1 (OSRAM)
CA (1) CA2606429A1 (OSRAM)
ES (1) ES2570758T3 (OSRAM)
IL (3) IL186710A (OSRAM)
MX (3) MX339202B (OSRAM)
NO (2) NO345667B1 (OSRAM)
NZ (2) NZ562661A (OSRAM)
RU (2) RU2449014C2 (OSRAM)
SG (2) SG10201910006WA (OSRAM)
WO (1) WO2006116082A1 (OSRAM)
ZA (1) ZA200708897B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2495326B1 (en) * 2005-04-21 2019-11-20 University of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8124335B2 (en) 2005-05-06 2012-02-28 Gen-Probe Incorporated Compositions and assays to detect influenza virus A and B nucleic acids
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
JP4667507B2 (ja) 2005-10-07 2011-04-13 ファイザー・プロダクツ・インク イヌインフルエンザを治療するワクチンおよび方法
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
CA2626489C (en) * 2005-10-19 2020-10-27 University Of Florida Research Foundation, Inc Materials and methods for respiratory disease control in canines
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7674469B2 (en) 2006-10-25 2010-03-09 Internet International B.V. Feline influenza vaccine and method of use
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
WO2014124319A2 (en) * 2013-02-07 2014-08-14 Massachusetts Institute Of Technology Human adaptation of h5 influenza
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
US20180187273A1 (en) * 2015-07-02 2018-07-05 Indevr Inc. Universal Priming Mixture for Amplification of Influenza Viral Gene Segments for Diagnostic Applications
MX2021014912A (es) * 2019-06-07 2022-01-18 Intervet Int Bv Celula mutante mdbk con inactivacion de irf3/irf7 y su uso para producir vacunas.
CN110592276A (zh) * 2019-07-08 2019-12-20 北京世纪元亨动物防疫技术有限公司 用于检测犬流感病毒的特异性引物及试剂盒
CN115074461B (zh) * 2021-03-11 2023-08-25 上海市农业科学院 犬流感病毒、犬冠状病毒和犬呼肠孤病毒的三重pcr检测方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
RU2193065C2 (ru) * 1994-03-14 2002-11-20 Мерк энд Ко. Инк. Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
ES2293639T3 (es) * 1994-03-30 2008-03-16 Connaught Technology Corporation Secuencias de nucleotidos y aminoacidos de los virus gb, gc y gd del herpes canino y sus usos.
GB9524395D0 (en) 1995-11-29 1996-01-31 Nickerson Biocem Ltd Promoters
US6252139B1 (en) 1996-07-18 2001-06-26 The Salk Institute For Biological Studies Method of increasing growth and yield in plants
US6063385A (en) 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
DE69929825T2 (de) 1998-11-24 2006-11-02 Pioneer Hi-Bred International, Inc. Wurzelspezifische promotoren und ihre anwendung
JP2000230931A (ja) * 1998-12-07 2000-08-22 Katakura Industries Co Ltd 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット
DE19960843A1 (de) 1999-12-16 2001-06-28 Florian Grundler Wurzelspezifischer Promotor
CN101580849B (zh) * 2000-04-28 2012-11-21 圣朱德儿童研究医院 用于产生感染性流感病毒的dna转染系统
IL153005A0 (en) * 2000-06-23 2003-06-24 American Cyanamid Co Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
US6455760B1 (en) 2000-11-16 2002-09-24 The Salk Institute Of Biological Studies Expression of flavin-containing monoxygenases in plants
US20040067506A1 (en) 2000-12-04 2004-04-08 Ben Scheres Novel root specific promoter driving the expression of a novel lrr receptor-like kinase
EP1980268A2 (en) * 2002-04-12 2008-10-15 Ilaria Capua Vaccination methods against avian influenza virus
US7285656B2 (en) 2002-04-26 2007-10-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Root-specific conifer gene promoter and its use
EP1658304A4 (en) * 2002-09-28 2009-01-14 Massachusetts Inst Technology THERAPY ANTIGRIPPALE
WO2004057021A2 (en) * 2002-12-19 2004-07-08 UNIVERSITé LAVAL Molecular methods and compositions for detecting and quantifying respiratory viruses
US20040123349A1 (en) 2002-12-20 2004-06-24 Qi Xie SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
CA2523676A1 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
CN1458168A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 重组猪流感病毒np抗原、其制备方法及在诊断中的应用
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
EP2495326B1 (en) * 2005-04-21 2019-11-20 University of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
JP4667507B2 (ja) * 2005-10-07 2011-04-13 ファイザー・プロダクツ・インク イヌインフルエンザを治療するワクチンおよび方法
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
CA2626489C (en) * 2005-10-19 2020-10-27 University Of Florida Research Foundation, Inc Materials and methods for respiratory disease control in canines
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Also Published As

Publication number Publication date
KR101738937B1 (ko) 2017-05-23
ZA200708897B (en) 2009-01-28
KR101738940B1 (ko) 2017-06-08
CN103451158B (zh) 2018-11-23
EP2489739A3 (en) 2013-08-28
NO342494B1 (no) 2018-06-04
CA2606429A1 (en) 2006-11-02
IL208707A0 (en) 2010-12-30
JP6663416B2 (ja) 2020-03-11
JP2018050636A (ja) 2018-04-05
NO20075961L (no) 2008-01-21
SG10201910006WA (en) 2019-11-28
EP1871885A4 (en) 2009-09-16
IL186710A (en) 2017-09-28
EP1871885B1 (en) 2016-02-17
IL249236A0 (en) 2017-01-31
CN107099512A (zh) 2017-08-29
CN101253267A (zh) 2008-08-27
IL186710A0 (en) 2008-02-09
BRPI0610503A2 (pt) 2010-06-29
WO2006116082A1 (en) 2006-11-02
JP2015144604A (ja) 2015-08-13
RU2011153597A (ru) 2013-07-10
RU2007143041A (ru) 2009-05-27
KR101474011B1 (ko) 2014-12-23
EP2495326B1 (en) 2019-11-20
JP2008536526A (ja) 2008-09-11
EP2489739B1 (en) 2019-11-20
RU2020100038A (ru) 2021-07-09
IL208707B (en) 2020-01-30
BRPI0610503B1 (pt) 2022-05-31
EP1871885A1 (en) 2008-01-02
MX339202B (es) 2016-05-13
KR20150082628A (ko) 2015-07-15
CN103451158A (zh) 2013-12-18
AU2006240038B2 (en) 2012-07-05
RU2449014C2 (ru) 2012-04-27
JP2020031658A (ja) 2020-03-05
NO345667B1 (no) 2021-06-07
NO20180601A1 (no) 2008-01-21
EP2495326A3 (en) 2013-08-28
BR122018012345B1 (pt) 2021-10-26
ES2570758T3 (es) 2016-05-20
KR20140091770A (ko) 2014-07-22
EP1871885B8 (en) 2017-08-02
IL249236B (en) 2021-07-29
JP2024043541A (ja) 2024-03-29
RU2711791C2 (ru) 2020-01-22
EP2495326A2 (en) 2012-09-05
HK1111729A1 (zh) 2008-08-15
AU2006240038A1 (en) 2006-11-02
NZ562661A (en) 2010-04-30
MX2018010571A (es) 2022-01-25
NZ583564A (en) 2011-09-30
JP2013031440A (ja) 2013-02-14
SG10201406043TA (en) 2014-11-27
JP6301855B2 (ja) 2018-03-28
KR20080039836A (ko) 2008-05-07
EP2489739A2 (en) 2012-08-22
JP6042131B2 (ja) 2016-12-14

Similar Documents

Publication Publication Date Title
MX2018010571A (es) Materiales y metodos para el control de enfermedades respiratorias en caninos.
MX341842B (es) Virus de la influenza capaces de infectar canidos y usos de los mismos.
Rasche et al. Evolutionary biology of human hepatitis viruses
WO2008121329A3 (en) Turkey herpesvirus vectored recombinant containing avian influenza genes
TW200732476A (en) Functional influenza virus like particles (VLPs)
MY143262A (en) Roller clutch
SG153829A1 (en) Identifying virally infected and vaccinated organisms
ATE554789T1 (de) Neues hundeinfluenza-virus und imfpstoff hierfür
EP2643029A4 (en) PREPARATION AND / OR FORMULATION OF POLYSACCHARIDE-NETWORKED PROTEINS
BRPI0923599A2 (pt) vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo
TW200730188A (en) Vaccines and methods to treat canine influenza
EA201001045A1 (ru) Модифицированный вирус гриппа
WO2007017759A3 (en) Creating poultry and other animals resistant to viral disease
ATE513561T1 (de) Veränderung des th1/th2-gleichgewichts in spalt- grippeimpfstoffen mit adjuvantien
EP2443260A4 (en) VIRAL ANALYSIS
ATE547116T1 (de) Kombinationsimpfstoff
WO2012089742A3 (en) IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
ATE544856T1 (de) Peptid- und nukleotidsequenzen von anisakis spp. und ihre verwendung
DK1973931T3 (da) Hønsevirusvaccine og -diagnosticering
TW200710224A (en) Attenuated avian infectious bronchitis virus vaccines
DK1945797T3 (da) Hepatitis C-virus NS2/3-aktivitetsanalyse
WO2008059018A3 (en) Vaccine for vaccinating felines and canines against influenza virus
BR112015002371A8 (pt) estirpes mutantes de neospora e o uso das mesmas
Wu et al. C26 TREATMENT OF RESPIRATORY INFECTIONS: Sulforaphane Increases Scavenger Receptor Marco Expression And Host Survival In A Model Of Post-Influenza Bacterial Pneumonia
Fujimoto et al. Anti-nucleocapsid protein antibody is sufficient to confer resistance to lethal infection with influenza A viruses of several subtypes in transgenic mice.